Indicateurs
1 Consultations de la notice
- Titre
- Feasibility and safety profile of high-dose oxaliplatin-based PIPAC (120mg/m2) in the treatment of advanced peritoneal metastatic disease: MINOS multicenter study
- Créateurs - sans rôle
- Diego Zambrano Pérez - Institut du Cancer Montpellier, Surgical Oncology Department, Montpellier, FranceAlexandru Lintis - CHU Lyon Sud, Visceral Surgery, Lyon, FranceAbdel Taibi - CHU Limoges, Surgery, Limoges, FranceAmaniel Kefleyesus - CHUV Lausanne, Surgery, Lausanne, SwitzerlandBarbara Noiret - CHU Lille, Surgery, Lille, FranceAlix Bouillin - Institut du Cancer Montpellier, Surgical Oncology Department, Montpellier, FranceGuillaume De Meeus - Institut du Cancer Montpellier, Surgical Oncology Department, Montpellier, FranceClarisse Eveno - CHU Lille, Surgery, Lille, FranceVahan Kepenekian - CHU Lyon Sud, Visceral Surgery, Lyon, FranceMartin Hübner - CHUV Lausanne, Surgery, Lausanne, SwitzerlandOlivier Glehen - CHU Lyon Sud, Visceral Surgery, Lyon, FranceOlivia A. Sgarbura - Cancer Institute in Montpellier, Surgical Oncology Department, Montpellier, France
- Détails de publication
- European journal of surgical oncology, Vol.50(2), p.107414
- Éditeur
- Elsevier Ltd
- Identifiants
- 99233873609311
- Unité académique
- IRCM - Institut de Recherche en Cancérologie de Montpellier
- Langue
- Anglais
- Type de ressource
- Article de revue scientifique